Delivery Order SPE2DB22D1200-SPE2DB24FN1MS
- Not listed
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,376.79, is for the delivery of Sevelamer Carbonate 800 mg tablets in unit doses of 50s. The contract has a completion date of December 11, 2024 and is a Firm Fixed Price Delivery Order. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of sevelamer carbonate 800 mg tablets. The contract has a ceiling value of $2,359.44 and an ultimate completion date of October 30, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Sevelamer HCL 800 mg tablets (180-count) with a contract ceiling value of $6,710.88. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion by September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,550.32 firm fixed-price delivery order is for the supply of sevelamer hydrochloride 800 mg tablets, a medication used to treat certain kidney conditions. The contract has an ultimate completion date of March 10, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This contract award to AmerisourceBergen Drug Corp's Corporate Office Division provides for the delivery of sevelamer carbonate 800 mg tablets to the Department of Defense's Medical Supply Chain (DLA Troop Support Medical). The $2,192.13 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract valued at up to $999,999,999 through December 2025 for pharmaceutical and medical supplies. This contract does not have a set-aside designation. AmerisourceBergen, one of the...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,347,314 units of Sevelamer Carbonate 800 mg tablets. The $1,728.00 order, placed under an indefinite delivery contract, is for the delivery of the pharmaceutical product to a performance location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,438.91, is for the delivery of sevelamer carbonate 800 mg tablets. It is a firm fixed-price delivery order with a completion date of January 3, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered as a for-profit organization in the System for Award Management...
- This is a $1,603.92 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RENVELA 800 MG TABLET 270S, a medication used to treat hyperphosphatemia. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $337.86 to Amerisourcebergen Drug Corporation for 4561558660 SEVELAMER HCL 800 MG TABLET 180S. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by July 21, 2023 to support the Defense Logistics Agency's medical supply needs. The parent company, Amerisourcebergen Corporation, will oversee performance through its...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,852.26 delivery order contract is for Renvela 800 mg tablets, a medication used to treat kidney disease. The contract has a firm fixed price and spans from the award date of January 22, 2024 through January 23, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a significant...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB24FN1MSDelivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company. The contract is for the supply of Sevelamer Carbonate 800 mg tablets, a medication used to treat high phosphorus levels in patients with chronic kidney disease. The contract has a ceiling value of $1,236.22 and a period of performance through March 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/26/24 |